Disease burden predicts for favorable post salvage cryoablation PSA

Urology

Volumn 76, Issue 5, 2010, Pages 1157-1161

  Levy, David A ^a   Li, Jianbo ^b   Jones, J Stephen ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE; ARTICLE; CLINICAL ARTICLE; CRYOABLATION; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE DISEASE; RACE DIFFERENCE; SALVAGE THERAPY; TREATMENT OUTCOME;

AGED; CRYOSURGERY; HUMANS; MALE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TUMOR BURDEN;

EID: 78149326955     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.01.053     Document Type: Article

References (24)

1. P.I. Karakiewicz, N. Bhojani, U. Capitanio, A.M. Reuther, N. Suardi, and C. Jeldres External validation of the updated Partin tables in a cohort of North American men J Urol. 180 3 2008 898 902
2. N. Bhojani, L. Salomon, U. Capitanio, N. Suardi, and S.F. Shariat External validation of the updated Partin tables in a cohort of French and Italian men Int J Radiat Oncol Biol Phys. 73 2 2009 347 352
3. A.V. D'Amico, J. Moul, P.R. Carroll, L. Sun, D. Lubeck, and M.H. Chen Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate specific antigen era J Clin Oncol. 21 2003 2163 2172
4. J. Molitierno, A. Evans, J.L. Mohler, E. Wallen, D. Moore, and R.S. Pruthi Characterization of biochemical recurrence after radical prostatectomy Urol Int. 77 2006 130 134
5. S. Sengupta, C.M. Christensen, H. Zinke, J.M. Slezak, B.C. Leibovich, and E.J. Bergstralh Detectable prostate specific antigen 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance J Urol. 176 2006 559 563
6. D.D. Lin, D. Schultz, A.A. Renshaw, M.A. Rubin, J.P. Richie, and A.V. D'Amico Predictors of short postoperative prostate specific antigen doubling time for patients diagnosed during the PSA era Urology 65 2005 528 532
7. A.E. Teeter, L.L. Banez, J.C. Presti, W.J. Aronson, M.K. Terris, and C.J. Kane What are factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group J Urol. 180 5 2008 1980 1984
8. A. Naselli, C. Introini, R. Andreatta, B. Spina, M. Truini, and P. Puppo Prognostic factors of persistently detectable PSA after radical prostatectomy Int J Urol. 16 1 2009 82 86
9. A.V. D'Amico, D. Schultz, B. Silver, L. Henry, M. Hurwitz, and I. Kaplan The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer Int J Radiat Oncol Biol Phys. 49 2001 679 684
10. S.J. Freedland, W.J. Aronson, M.K. Terris, C.J. Kane, C.L. Amling, F. Dorey SEARCH Database Study group Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database J Urol. 169 2003 2136 2141
11. P. Harnden, M.D. Shelly, B. Naylor, B. Coles, and M.D. Mason Does the extent of carcinoma in prostatic biopsies predict prostate-specific antigen recurrence? A systematic review Eur Urol. 54 4 2008 728 739
12. T.J. Sebo, B.J. Bock, J.C. Cheville, C. Lohse, P. Wollan, and H. Zinke The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy J Urol. 163 1 2000 179 180
13. A.C. Spalding, S. Daignault, H.M. Sandler, R.B. Shah, C.C. Pan, and M.E. Ray Percent positive biopsy cores as a prognostic factor for prostate cancer treated with external beam radiation Urology 69 5 2007 936 940
14. T. Wiegel, G. Lohm, S. Hocht, K. Miller, and A. Siegman Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcomeresults of a retrospective study Int J Radiat Oncol Biol Phys. 73 4 2009 1009 1016
15. D. Pasquier, and C. Ballereau Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review Int J Radiat Oncol Biol Phys. 72 4 2008 972 979
16. G. De Meerleer, V. Fonteyne, S. Meersschout, C. Van den Broecke, and N. Villiers Glumen Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy Radiother Oncol. 89 2 2008 205 213
17. L.L. Pisters, D. Leibovici, M. Blute, H. Zinke, T.J. Sebo, and J.M. Slezak Locally recurrent prostate cancer after initial radiation therapy: A comparison of salvage radical prostatectomy versus cryotherapy J Urol. 182 2009 517 525
18. D. Leibovici, P.E. Spiess, L. Heller, M. Rodriguez-Bigas, G. Chang, and L.L. Pisters Salvage surgery for locally recurrent prostate cancer after radiation therapy: trick of the trade Urol Oncol. 26 1 2008 9 16
19. K.M. Sanderson, D.F. Penson, J. Cai, S. Groshen, J.P. Stein, G. Lieskovsky, and D.G. Skinner Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer J Urol. 176 5 2006 2025 2031
20. D.A. Levy, L.L. Pisters, and J.S. Jones Prognostic value of initial salvage cryoablation PSA BJUI 2009 In press
21. R.J. Babaian, B. Donnelly, D. Bahn, J.G. Baust, M. Dineen, and D. Ellis Best practice statement on cryosurgery for the treatment of localized prostate cancer J Urol. 180 2008 1993 2004
22. D.A. Levy, L.L. Pisters, and J.S. Jones Primary cryoablation nadir prostate specific antigen and biochemical failure J Urol. 182 2009 931 937
23. D.A. Levy, J. Li, and J.S. Jones Impact of disease burden on cryoablation PSA outcomes Urology 75 2009 478 481
24. A.V. D'Amico, J. Moul, P.R. Carroll, L. Sun, D. Lubeck, and M.H. Chen Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate specific antigen era J Clin Oncol. 21 2003 2163 2172